Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance (in shares) at Mar. 31, 2020 [1]   87,147,023 100,000 758,125 [2]        
Beginning balance at Mar. 31, 2020 [1] $ 77,454 $ 10 $ 100 $ (71) $ 360,224 $ (591) $ (282,218) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income [1] 9,940           9,940  
Foreign currency translation [1] (142)         (142)    
Stock-based compensation expense [1] 1,611       1,611      
Exercise of stock options (in shares) [1]   224,012            
Exercise of stock options [1] 437       437      
Ending balance (in shares) at Jun. 30, 2020 [1]   87,371,035 100,000 758,125 [2]        
Ending balance at Jun. 30, 2020 [1] 89,300 $ 10 $ 100 $ (71) 362,272 (733) (272,278) 0
Beginning balance (in shares) at Mar. 31, 2020 [1]   87,147,023 100,000 758,125 [2]        
Beginning balance at Mar. 31, 2020 [1] 77,454 $ 10 $ 100 $ (71) 360,224 (591) (282,218) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income [3] 24,828              
Foreign currency translation [3] (319)              
Ending balance (in shares) at Dec. 31, 2020 [1]   89,249,322 100,000 758,125 [2]        
Ending balance at Dec. 31, 2020 [1] 112,174 $ 10 $ 100 $ (71) 370,435 (910) (257,390) 0
Beginning balance (in shares) at Jun. 30, 2020 [1]   87,371,035 100,000 758,125 [2]        
Beginning balance at Jun. 30, 2020 [1] 89,300 $ 10 $ 100 $ (71) 362,272 (733) (272,278) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income [1] 373           373  
Foreign currency translation [1] (45)         (45)    
Stock-based compensation (in shares) [1]   106,663            
Stock-based compensation expense [1] 2,515       2,515      
Exercise of stock options (in shares) [1]   1,059,644            
Exercise of stock options [1] 3,089       3,089      
Ending balance (in shares) at Sep. 30, 2020 [1]   88,537,342 100,000 758,125 [2]        
Ending balance at Sep. 30, 2020 [1] 95,232 $ 10 $ 100 $ (71) 367,876 (778) (271,905) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 14,515 [3]           14,515 [1]  
Foreign currency translation [1] (132)         (132)    
Stock-based compensation (in shares) [1]   15,768            
Stock-based compensation expense [1] 160       160      
Exercise of stock options (in shares) [1]   696,212            
Exercise of stock options [1] 2,399       2,399      
Ending balance (in shares) at Dec. 31, 2020 [1]   89,249,322 100,000 758,125 [2]        
Ending balance at Dec. 31, 2020 [1] 112,174 $ 10 $ 100 $ (71) 370,435 (910) (257,390) 0
Beginning balance (in shares) at Mar. 31, 2021 [1]   89,790,086 100,000 758,125        
Beginning balance at Mar. 31, 2021 [1] 145,112 $ 10 $ 100 $ (71) 373,310 (903) (227,334) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income [1] 14,253           14,284 (31)
Foreign currency translation [1] (20,781)         (20,019)   (762)
Stock-based compensation (in shares) [1]   207,758            
Stock-based compensation expense [1] 3,705       3,705      
Exercise of stock options (in shares) [1]   178,127            
Exercise of stock options [1] 695       695      
Shares for acquisition of Fyber (in shares) [1]   4,716,935            
Shares for acquisition of Fyber [1] 359,233       359,233      
Acquisition of non-controlling interests in Fyber [1] 24,558             24,558
Ending balance (in shares) at Jun. 30, 2021 [1]   94,892,906 100,000 758,125        
Ending balance at Jun. 30, 2021 [1] 526,775 $ 10 $ 100 $ (71) 736,943 (20,922) (213,050) 23,765
Beginning balance (in shares) at Mar. 31, 2021 [1]   89,790,086 100,000 758,125        
Beginning balance at Mar. 31, 2021 [1] 145,112 $ 10 $ 100 $ (71) 373,310 (903) (227,334) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income [3] 15,428              
Foreign currency translation [3] $ (45,062)              
Exercise of stock options (in shares) 859,564              
Ending balance (in shares) at Dec. 31, 2021 [1]   96,731,227 100,000 758,125        
Ending balance at Dec. 31, 2021 [1] $ 485,866 $ 10 $ 100 $ (71) 740,592 (45,051) (211,888) 2,174
Beginning balance (in shares) at Jun. 30, 2021 [1]   94,892,906 100,000 758,125        
Beginning balance at Jun. 30, 2021 [1] 526,775 $ 10 $ 100 $ (71) 736,943 (20,922) (213,050) 23,765
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income [1] (5,887)           (5,852) (35)
Foreign currency translation [1] (15,892)         (15,799)   (93)
Stock-based compensation (in shares) [1]   28,477            
Stock-based compensation expense [1] 5,925       5,925      
Exercise of stock options (in shares) [1]   480,422            
Exercise of stock options [1] 1,460       1,460      
Shares for acquisition of Fyber (in shares) [1]   1,058,364            
Shares for acquisition of Fyber [1] (2,547)       (2,547)      
Acquisition of non-controlling interests in Fyber [1] (21,452)             (21,452)
Ending balance (in shares) at Sep. 30, 2021 [1]   96,460,169 100,000 758,125        
Ending balance at Sep. 30, 2021 [1] 488,382 $ 10 $ 100 $ (71) 741,781 (36,721) (218,902) 2,185
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 7,062 [3]           7,014 [1] 48 [1]
Foreign currency translation (8,389) [3]         (8,330) [1]   (59) [1]
Stock-based compensation expense [1] 5,739       5,739      
Exercise of stock options (in shares) [1]   201,015            
Exercise of stock options [1] 659       659      
Vesting of restricted and performance stock units (in shares) [1]   70,043            
Payment of withholding taxes related to the net share settlement of equity awards [1] (7,587)       (7,587)      
Ending balance (in shares) at Dec. 31, 2021 [1]   96,731,227 100,000 758,125        
Ending balance at Dec. 31, 2021 [1] $ 485,866 $ 10 $ 100 $ (71) $ 740,592 $ (45,051) $ (211,888) $ 2,174
[1] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 4 in the accompanying condensed consolidated financial statements.
[2] De minimis adjustment to previously disclosed share count; no impact on quarter-to-date or year-to-date earnings per share in any period presented.
[3] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 4 in the accompanying condensed consolidated financial statements.